XB
X Bioscience Public Company Limited
XBIO.BK · SET
฿0.06 -0.00% (-฿0.00)
1M -28.57%
Market Cap ฿118.4M
P/E Ratio -
Div. Yield -
ROE 243.92%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.40x
P/S 0.57x
PEG N/A
Growth
0 /100
Declining Book val. growth 8.64%
Rev. growth 8.18%
FCF growth N/A
Profitability
16 /100
Weak FCF margin 159.86%
Op. margin 417.53%
Gross margin 39.93%
Quality
4 /100
Poor Asset turnover 0.33x
ROA 107.76%
ROIC 173.58%
Debt
54 /100
Moderate Current ratio 1.30x
Int. coverage -43.29x
Debt/Equity 0.44x
Stability
56 /100
Moderate Profitable years 0
EPS volatility 43.36%
Beta -0.23x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XBIO.BK
Online
Sector
Consumer Cyclical
Industry
Restaurants
CEO
Amnart Lertpresertwong
Employees
399
Headquarters
Bangkok